Scholarly Index
Varsha Gandhi
The University of Texas MD Anderson Cancer Center; 19,036 total citations; 439 total publications; best world rank #56
The University of Texas MD Anderson Cancer Center
19,036Total citations
439Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Biochemical and Molecular Research | Lifetime | 56 | US 35 | 99.18 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 229 | US 118 | 99.31 |
| Acute Lymphoblastic Leukemia research | Lifetime | 197 | US 115 | 99.18 |
| Cancer Mechanisms and Therapy | Lifetime | 139 | US 71 | 98.44 |
| Acute Myeloid Leukemia Research | Lifetime | 411 | US 192 | 98.85 |
| Cancer therapeutics and mechanisms | Lifetime | 326 | US 190 | 98.21 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 372 | US 190 | 98.24 |
| HIV/AIDS drug development and treatment | Lifetime | 675 | US 347 | 97.87 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 670 | US 283 | 97.39 |
| Multiple Myeloma Research and Treatments | Lifetime | 519 | US 233 | 97.40 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 433 | US 252 | 96.73 |
| Cell death mechanisms and regulation | Lifetime | 607 | US 252 | 96.08 |
| Phagocytosis and Immune Regulation | Lifetime | 553 | US 228 | 92.67 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 335 | US 150 | 96.45 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 388 | US 180 | 93.03 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 844 | US 279 | 61.62 |